Novel mechanisms and devices to enable successful transdermal drug delivery.

[1]  R. Guy,et al.  Reverse iontophoresis — Parameters determining electroosmotic flow: I. pH and ionic strength , 1996 .

[2]  Seung Hun Lee,et al.  The Pretreatment Effect of Chemical Skin Penetration Enhancers in Transdermal Drug Delivery Using Iontophoresis , 1999, Skin Pharmacology and Physiology.

[3]  G. E. El Maghraby,et al.  Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. , 2000, International journal of pharmaceutics.

[4]  Howard I. Maibach,et al.  Evaluation of the Barrier Function of Skin Using Transepidermal Water Loss (TEWL): A Critical Overview , 2014 .

[5]  J. Mccall,et al.  Physicochemical studies of lidocaine-menthol binary systems for enhanced membrane transport. , 2000, International journal of pharmaceutics.

[6]  Prausnitz.  A practical assessment of transdermal drug delivery by skin electroporation. , 1999, Advanced drug delivery reviews.

[7]  Adrian C. Williams,et al.  The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs , 1991 .

[8]  J Hadgraft,et al.  Passive enhancement strategies in topical and transdermal drug delivery. , 1999, International journal of pharmaceutics.

[9]  J. Weaver,et al.  Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  B. W. Barry,et al.  Sesquiterpene Components of Volatile Oils as Skin Penetration Enhancers for the Hydrophilic Permeant 5‐Fluorouracil , 1994, The Journal of pharmacy and pharmacology.

[11]  Geoffrey Lee.  Prediction of Percutaneous Penetration , 1997 .

[12]  C. Chiang,et al.  Effects of pH, electric current, and enzyme inhibitors on iontophoresis of delta sleep-inducing peptide. , 1998, Drug development and industrial pharmacy.

[13]  V. Préat,et al.  Electrically enhanced transdermal delivery of domperidone , 1997 .

[14]  I. Sugimoto,et al.  Enhancement of transdermal delivery by superfluous thermodynamic potential. II. In vitro-in vivo correlation of percutaneous nifedipine transport. , 1987, Journal of pharmacobio-dynamics.

[15]  W. Reilly.  Novel Cosmetic Delivery Systems , 2000 .

[16]  J. Weaver,et al.  Microfabrication of individual 200 microm diameter transdermal microconduits using high voltage pulsing in salicylic acid and benzoic acid. , 2001, The Journal of investigative dermatology.

[17]  A. Supersaxo,et al.  Sebaceous-gland deposition of isotretinoin after topical application: an in vitro study using human facial skin. , 1997, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[18]  B. Ongpipattanakul,et al.  Characterization of the permselective properties of excised human skin during iontophoresis. , 1987, Journal of pharmaceutical sciences.

[19]  R. Lipp.  Pharmaceutics: Selection and Use of Crystallization Inhibitors for Matrix‐type Transdermal Drug‐delivery Systems Containing Sex Steroids * , 1998, The Journal of pharmacy and pharmacology.

[20]  Asbill,et al.  Percutaneous penetration enhancers: local versus transdermal activity. , 2000, Pharmaceutical science & technology today.

[21]  V. Préat,et al.  Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Q. Ping,et al.  Lecithin vesicular carriers for transdermal delivery of cyclosporin A. , 2000, International journal of pharmaceutics.

[23]  J. Bouwstra,et al.  Modes of action of terpene penetration enhancers in human skin; Differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies , 1996 .

[24]  J Hadgraft,et al.  Membrane penetration enhancement of ibuprofen using supersaturation. , 2000, International journal of pharmaceutics.

[25]  N. Byl,et al.  The use of ultrasound as an enhancer for transcutaneous drug delivery: phonophoresis. , 1995, Physical therapy.

[26]  G. Cevc,et al.  Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.

[27]  M. Allen,et al.  Microfabricated microneedles: a novel approach to transdermal drug delivery. , 1998, Journal of pharmaceutical sciences.

[28]  J. A. Gimm,et al.  Transdermal Delivery of Heparin by Skin Electroporation , 1995, Bio/Technology.

[29]  Y. Chien,et al.  Iontophoresis-facilitated transdermal delivery of verapamil. II. Factors affecting the reversibility of skin permeability , 1989 .

[30]  P. Elias,et al.  High-frequency sonophoresis: permeation pathways and structural basis for enhanced permeability. , 1994, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[31]  H. Maibach,et al.  Classification of percutaneous penetration enhancers: A conceptional diagram , 1990, The Journal of pharmacy and pharmacology.

[32]  James C. Weaver,et al.  Electroporation of cells and tissues , 2000 .

[33]  W. Higuchi,et al.  Baseline studies on iontophoretic transport in hairless mouse skin: the effect of applied voltage drop and ph on the iontophoresis of a model weak electrolyte , 1990 .

[34]  N. A. Megrab,et al.  Oestradiol permeation through human skin and silastic membrane : effects of propylene glycol and supersaturation , 1995 .

[35]  M. Cima,et al.  A controlled-release microchip , 1999, Nature.

[36]  B. Bellhouse,et al.  Bioavailability following transdermal powdered delivery (TPD) of radiolabeled inulin to hairless guinea pigs , 1997 .

[37]  Jagdish Singh,et al.  Effect of current density on the iontophoretic permeability of benzyl alcohol and surface characteristics of human epidermis , 1998 .

[38]  R. Guy,et al.  Sites of iontophoretic current flow into the skin: identification and characterization with the vibrating probe electrode. , 1991, The Journal of investigative dermatology.

[39]  E. Touitou,et al.  Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. , 2000, Biomaterials.

[40]  N. Wagner,et al.  Skin distribution and pharmaceutical aspects of adapalene gel. , 1997, Journal of the American Academy of Dermatology.

[41]  G. A. Hofmann,et al.  Enhancement of Transdermal Iontophoretic Delivery of a Liposomal Formulation of Colchicine by Electroporation , 1999 .

[42]  N. Weiner,et al.  Bioavailability assessment of topical delivery systems: effect of vehicle evaporation upon in vitro delivery of minoxidil from solution formulations , 1989 .

[43]  M. Roberts,et al.  Effect of Ion Pairing with Alkylamines on the In‐vitro Dermal Penetration and Local Tissue Disposition of Salicylates , 2000, The Journal of pharmacy and pharmacology.

[44]  B. W. Barry,et al.  Mechanistic study into the enhanced transdermal permeation of a model beta-blocker, propranolol, by fatty acids: a melting point depression effect. , 2001, International journal of pharmaceutics.

[45]  Jia-You Fang,et al.  Transdermal delivery of sodium nonivamide acetate from volatile vehicles: effects of polymers , 1999 .

[46]  T Terahara,et al.  Determination of threshold energy dose for ultrasound-induced transdermal drug transport. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[47]  I. Sugimoto,et al.  Enhancement of transdermal delivery by superfluous thermodynamic potential. I. Thermodynamic analysis of nifedipine transport across the lipoidal barrier. , 1987, Journal of pharmacobio-dynamics.

[48]  B. Ongpipattanakul,et al.  Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis. , 1988, Journal of pharmaceutical sciences.

[49]  H. Maibach,et al.  Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery , 1989 .

[50]  M. A. Khan,et al.  Chirality and its implications in transdermal drug development. , 2000, Critical reviews in therapeutic drug carrier systems.

[51]  S. Mitragotri,et al.  Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery. , 1996, Journal of pharmaceutical sciences.

[52]  B. Godin,et al.  Enhanced delivery of drugs into and across the skin by ethosomal carriers , 2000 .

[53]  H. Abramson,et al.  SKIN REACTIONS: XII. PATTERNS PRODUCED IN THE SKIN BY ELECTROPHORESIS OF DYES , 1941 .

[54]  M. Singh,et al.  Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. , 2000, Current medicinal chemistry.

[55]  V. Préat,et al.  Electroporation-mediated delivery of 3'-protected phosphodiester oligodeoxynucleotides to the skin. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[56]  K. Sugibayashi,et al.  Skin penetration-enhancing effect of drugs by phonophoresis , 1995 .

[57]  Mary S. Wu,et al.  Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. , 2000, Vaccine.

[58]  R. Chilcott,et al.  The electrostability and electrically assisted delivery of an organophosphate pretreatment (physostigmine) across human skin in vitro. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[59]  R H Guy,et al.  Iontophoresis—Recent Developments * , 1998, The Journal of pharmacy and pharmacology.

[60]  S. Mitragotri,et al.  A mechanistic study of ultrasonically-enhanced transdermal drug delivery. , 1995, Journal of pharmaceutical sciences.

[61]  T. R. Krishnan,et al.  Topical delivery of cyclosporin A coevaporate using electroporation technique , 1997 .

[62]  Ajay K. Banga,et al.  Electrically Assisted Transdermal And Topical Drug Delivery , 1998 .

[63]  Adrian C. Williams,et al.  Skin Delivery of Oestradiol from Deformable and Traditiona Liposomes: Mechanistic Studies , 1999, The Journal of pharmacy and pharmacology.

[64]  J. Bouwstra,et al.  Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery , 1994 .

[65]  G. Cevc,et al.  Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. , 1992, Anesthesia and analgesia.

[66]  M. Roberts,et al.  ULTRASTRUCTURAL EFFECTS OF SOME SOLVENTS AND VEHICLES ON THE STRATUM CORNEUM AND OTHER SKIN COMPONENTS : EVIDENCE FOR AN EXTENDED MOSAIC-PARTITIONING MODEL OF THE SKIN BARRIER , 1998 .

[67]  J. Weaver,et al.  Heparin alters transdermal transport associated with electroporation. , 1997, Biochemical and biophysical research communications.

[68]  P. Khavari,et al.  Immunization via hair follicles by topical application of naked DNA to normal skin , 1999, Nature Biotechnology.

[69]  V. Meidan,et al.  Methods for quantitative determination of drug localized in the skin. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[70]  G. E. El Maghraby,et al.  Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. , 2000, International journal of pharmaceutics.

[71]  M. Southam,et al.  Effect of current density on pharmacokinetics following continuous or intermittent input from a fentanyl electrotransport system. , 1998, Journal of pharmaceutical sciences.

[72]  G. A. Hofmann,et al.  Electro-incorporation of microcarriers as a method for the transdermal delivery of large molecules , 1995 .

[73]  M. Mezei,et al.  Liposomes—A selective drug delivery system for the topical route of administration: gel dosage form , 1982, The Journal of pharmacy and pharmacology.

[74]  J. A. Gimm,et al.  Imaging regions of transport across human stratum corneum during high-voltage and low-voltage exposures. , 1996, Journal of pharmaceutical sciences.

[75]  R. Langer,et al.  Biomaterials in drug delivery and tissue engineering: one laboratory's experience. , 2000, Accounts of chemical research.

[76]  A. El‐Kattan,et al.  Enhancement of transdermal drug delivery: chemical and physical approaches. , 2000, Critical reviews in therapeutic drug carrier systems.

[77]  S. Mitragotri,et al.  Synergistic effect of low-frequency ultrasound and sodium lauryl sulfate on transdermal transport. , 2000, Journal of pharmaceutical sciences.

[78]  B. W. Barry,et al.  Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[79]  C. Tacket,et al.  Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. , 1999, Vaccine.

[80]  V. Préat,et al.  Factors affecting transdermal delivery of metoprolol by electroporation , 1995 .

[81]  Teissié,et al.  Electropermeabilization of cell membranes. , 1999, Advanced drug delivery reviews.

[82]  J Kost,et al.  Analysis of ultrasonically extracted interstitial fluid as a predictor of blood glucose levels. , 2000, Journal of applied physiology.

[83]  J. Weaver,et al.  Transdermal transport of DNA antisense oligonucleotides by electroporation. , 1995, Biochemical and biophysical research communications.

[84]  J. Hadgraft,et al.  Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique , 1997 .

[85]  Préat,et al.  In vivo efficacy and safety of skin electroporation. , 1999, Advanced drug delivery reviews.

[86]  J. Weaver,et al.  Creation of transdermal pathways for macromolecule transport by skin electroporation and a low toxicity, pathway-enlarging molecule. , 1999, Bioelectrochemistry and bioenergetics.

[87]  W I Higuchi,et al.  Quantitative description of the effect of molecular size upon electroosmotic flux enhancement during iontophoresis for a synthetic membrane and human epidermal membrane. , 1996, Journal of pharmaceutical sciences.

[88]  M. Mezei.  Biodisposition of Liposome-Encapsulated Active Ingredients Applied on the Skin , 1992 .

[89]  H. Zhu,et al.  Mechanistic aspects of iontophoresis in human epidermal membrane. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[90]  B. Godin,et al.  Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[91]  A. Schätzlein,et al.  Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo , 1997 .

[92]  Jadoul,et al.  Effects of iontophoresis and electroporation on the stratum corneum. Review of the biophysical studies. , 1999, Advanced drug delivery reviews.

[93]  J. Weaver,et al.  Spatially constrained skin electroporation with sodium thiosulfate and urea creates transdermal microconduits. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[94]  B. W. Barry,et al.  Action of skin penetration enhancers—the Lipid Protein Partitioning theory , 1988, International journal of cosmetic science.

[95]  Adrian C. Williams,et al.  Characterization of complex coacervates of some tricyclic antidepressants and evaluation of their potential for enhancing transdermal flux , 1996 .

[96]  T. Redelmeier,et al.  Skin Barrier: Principles of Percutaneous Absorption , 1996 .

[97]  J. Dover,et al.  Lasers in skin resurfacing. , 2000, The Australasian journal of dermatology.

[98]  Steven M. Dinh,et al.  Electronically controlled drug delivery , 1998 .

[99]  Jonathan Hadgraft,et al.  Effect of supersaturation on membrane transport: 1. Hydrocortisone acetate , 1991 .

[100]  J. Hadgraft,et al.  The dermal delivery of lignocaine: influence of ion pairing. , 2000, International journal of pharmaceutics.

[101]  C. Bangham,et al.  Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system. , 1998, Vaccine.

[102]  M. Allen,et al.  Microfabricated microneedles for gene and drug delivery. , 2000, Annual review of biomedical engineering.

[103]  J. Weaver,et al.  Charged microbeads are not transported across the human stratum corneum in vitro by short high-voltage pulses. , 1999, Bioelectrochemistry and bioenergetics.

[104]  A. Schätzlein,et al.  TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES , 1995 .

[105]  L. Miller,et al.  Transdermal iontophoresis of gonadotropin releasing hormone (LHRH) and two analogues. , 1990, Journal of pharmaceutical sciences.

[106]  J. Hadgraft,et al.  Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. , 2000, International journal of pharmaceutics.

[107]  M. Mezei,et al.  Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form. , 1980, Life sciences.

[108]  J. Hadgraft,et al.  Effect of supersaturation on membrane transport: 2. Piroxicam , 1994 .

[109]  J. Simonin.  On the mechanisms of in vitro and in vivo phonophoresis , 1995 .

[110]  S Grimnes,et al.  Pathways of ionic flow through human skin in vivo. , 1984, Acta dermato-venereologica.

[111]  R. Hoffman.  The hair follicle as a gene therapy target , 2000, Nature Biotechnology.

[112]  J. Kristl,et al.  Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[113]  J Kost,et al.  Low‐Frequency Sonophoresis: A Noninvasive Method of Drug Delivery and Diagnostics , 2000, Biotechnology progress.

[114]  M. Fujii,et al.  Application of an oily gel formed by hydrogenated soybean phospholipids as a percutaneous absorption-type ointment base. , 1994, Chemical & pharmaceutical bulletin.

[115]  P. Iversen,et al.  Effects of size and sequence on the iontophoretic delivery of oligonucleotides. , 1998, Journal of pharmaceutical sciences.

[116]  A. Brodin,et al.  Drug release studies on an oil-water emulsion based on a eutectic mixture of lidocaine and prilocaine as the dispersed phase. , 1986, Journal of pharmaceutical sciences.

[117]  K. Oldenburg,et al.  Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin. , 1995, Journal of pharmaceutical sciences.

[118]  V. Préat,et al.  Mechanisms of a Phosphorothioate Oligonucleotide Delivery by Skin Electroporation , 1998 .

[119]  R. Potts,et al.  Pulsatile transdermal delivery of LHRH using electroporation: Drug delivery and skin toxicology , 1995 .

[120]  M. Takada,et al.  Effect of pulsed output ultrasound on the transdermal absorption of indomethacin from an ointment in rats. , 1997, Biological & pharmaceutical bulletin.

[121]  P. Upadhyay,et al.  Needle-free, non-adjuvanted skin immunization by electroporation-enhanced transdermal delivery of diphtheria toxoid and a candidate peptide vaccine against hepatitis B virus. , 1999, Vaccine.

[122]  W. J. Irwin,et al.  Ionisation and the effect of absorption enhancers on transport of salicylic acid through silastic rubber and human skin. , 2000, International journal of pharmaceutics.

[123]  B. W. Barry.  Lipid-Protein-Partitioning theory of skin penetration enhancement , 1991 .

[124]  F. Levi-Schaffer,et al.  Modulation of caffeine skin delivery by carrier design: liposomes versus permeation enhancers , 1994 .

[125]  L. Coderch,et al.  Influence of the Fluidity of Liposome Compositions on Percutaneous Absorption , 2000, Drug delivery.

[126]  T. Higuchi,et al.  Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles. , 1969, Journal of Pharmacy and Science.

[127]  V. Sinha,et al.  Permeation Enhancers for Transdermal Drug Delivery , 2000, Drug development and industrial pharmacy.

[128]  Brian W. Barry,et al.  Dermatological Formulations: Percutaneous Absorption , 1983 .

[129]  J. Friedland,et al.  Skin care and the topical treatment of aging skin. , 2000, Clinics in plastic surgery.

[130]  J. Hadgraft,et al.  The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro , 1997 .

[131]  K. Bhatia,et al.  Synergistic effect of iontophoresis and a series of fatty acids on LHRH permeability through porcine skin. , 1998, Journal of pharmaceutical sciences.

[132]  Michael Goodman,et al.  Lipid-protein-partitioning (LPP) theory of skin enhancer activity: finite dose technique , 1989 .

[133]  M. Roberts,et al.  Ion‐pair Formation as a Strategy to Enhance Topical Delivery of Salicylic Acid , 2000, The Journal of pharmacy and pharmacology.

[134]  J. Bouwstra,et al.  Wide‐angle X‐ray Diffraction of Human Stratum Corneum: Effects of Hydration and Terpene Enhancer Treatment , 1994, The Journal of pharmacy and pharmacology.

[135]  Adrian C. Williams,et al.  Skin delivery of 5‐fluorouracil from ultradeformable and standard liposomes in‐vitro , 2001, The Journal of pharmacy and pharmacology.

[136]  Russell O. Potts,et al.  Measurement of glucose in diabetic subjects using noninvasive transdermal extraction , 1995, Nature Medicine.

[137]  S. Mitragotri,et al.  Ultrasound-mediated transdermal protein delivery , 1995, Science.

[138]  A. Schätzlein,et al.  The skin: a pathway for systemic treatment with patches and lipid-based agent carriers , 1996 .

[139]  Wen-Yih Chen,et al.  The role of electroosmotic flow on in-vitro transdermal iontophoresis , 1997 .

[140]  Y. Kalia,et al.  Transdermal drug delivery: overcoming the skin's barrier function. , 2000, Pharmaceutical science & technology today.

[141]  M. Fresta,et al.  Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles. , 1996, Journal of drug targeting.

[142]  G. A. Hofmann,et al.  In vivo transdermal delivery of large molecules by pressure-mediated electroincorporation and electroporation: a novel method for drug and gene delivery☆ , 1997 .

[143]  G. Cevc.  Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. , 1996, Critical reviews in therapeutic drug carrier systems.

[144]  Adrian C. Williams,et al.  Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes , 2001, The Journal of pharmacy and pharmacology.

[145]  G. Cevc,et al.  Transdermal immunization with large proteins by means of ultradeformable drug carriers , 1995, European journal of immunology.

[146]  M. McArthur,et al.  Transdermal extraction of interstitial fluid by low-frequency ultrasound quantified with 3H2O as a tracer molecule. , 2000, Journal of pharmaceutical sciences.

[147]  P. Jahrling,et al.  DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. , 1998, Virology.

[148]  Murthy Sn,et al.  Magnetophoresis: an approach to enhance transdermal drug diffusion. , 1999 .

[149]  Y. Kalia,et al.  Non‐invasive assessment of the effects of iontophoresis on human skin in‐vivo , 2001, The Journal of pharmacy and pharmacology.

[150]  B. Bellhouse,et al.  Transdermal and transmucosal powdered drug delivery. , 1999, Critical reviews in therapeutic drug carrier systems.

[151]  N. Weiner.  Targeted follicular delivery of macromolecules via liposomes , 1998 .

[152]  T. Ghosh,et al.  Iontophoresis and electroporation: comparisons and contrasts. , 1999, International journal of pharmaceutics.

[153]  I. Sugimoto,et al.  Enhancement of transdermal delivery by superfluous thermodynamic potential. III. Percutaneous absorption of nifedipine in rats. , 1987, Journal of pharmacobio-dynamics.

[154]  A. Müller-Fahrnow,et al.  Use of X-ray crystallography for the characterization of single crystals grown in steroid containing transdermal drug delivery systems. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[155]  G. A. Hofmann,et al.  The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[156]  O. Katare,et al.  The pilosebaceous unit: a pivotal route for topical drug delivery. , 2000, Methods and findings in experimental and clinical pharmacology.

[157]  H. Maibach,et al.  Physical and physiological effects of stratum corneum tape stripping , 2001, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[158]  Lukchiu Li,et al.  Effect of Sodium Dodecyl Sulfate on Iontophoresis of Hydrocortisone Across Hairless Mouse Skin , 2000, Pharmaceutical development and technology.

[159]  Y. Gross,et al.  A microinfusor device for the delivery of therapeutic levels of peptides and macromolecules , 1997 .

[160]  V. Préat,et al.  Parameters controlling topical delivery of oligonucleotides by electroporation. , 1998, Journal of drug targeting.

[161]  R. Hoffman,et al.  Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases. , 1996, Biochemical and biophysical research communications.

[162]  N. Weiner,et al.  Controlled Topical Delivery of Cyclosporin-a from Nonionic Liposomal Formulations: Mechanistic Aspects , 1998 .